Prokidney saw the highest growth of 1.99% in patent filings in May and 1.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 1.49%. GlobalData’s DataBook provides a comprehensive analysis of Prokidney’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Discover B2B Marketing That Performs
Combine business intelligence and editorial excellence to reach engaged professionals across 36 leading media platforms.
Prokidney has been focused on protecting inventions in Australia(AU) with two publications in Q2 2024
The Australia(AU) Patent Office dominates the patent filings and grants with nearly 25% filings and 20% grants. The United States(US), Australia(AU), European Patent Office(EPO), and Spain(ES) patent Office are among the top ten patent offices where Prokidney is filings its patents. Among the top granted patent authorities, Prokidney has 20% of its grants in Australia(AU), 20% in Spain(ES) and 20% in Croatia(HR).
Kyoto University could be the strongest competitor for Prokidney
Patents related to rare diseases and cell & gene therapy lead Prokidney's portfolio
Prokidney has the highest number of patents in rare diseases followed by, cell & gene therapy. For rare diseases, nearly 100% of patents were filed and 80% of patents were granted in Q2 2024.
Kidney disease (nephropathy) related patents lead Prokidney portfolio followed by chronic kidney disease (chronic renal failure), and drug delivery devices
Prokidney has highest number of patents in kidney disease (nephropathy) followed by chronic kidney disease (chronic renal failure), drug delivery devices, general surgery devices, and congestive heart failure (heart failure). For kidney disease (nephropathy), nearly 20% of patents were filed and 100% of patents were granted in Q2 2024.
For comprehensive analysis of Prokidney's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
